Six biochemical and genetic forms of methylmalonic acidemia have been defined previously: two (mut degrees and mut-) resulting from defects in the mutase apoenzyme, and four (cbl A, cbl B, cbl C, and cbl D) resulting from deficient adenosylcobalamin synthesis. We retrospectively surveyed the clinical presentation, response to cobalamin supplementation, and long-term outcome in the four most prevalent mutant classes by collecting detailed information on 45 patients (15 mut degrees, 5 mut-, 14 cbl A, and 11 cbl B). Most patients presented acutely with a common set of clinical and laboratory findings; however, there were significant differences between mutant classes: mut degrees patients presented earlier in infancy than did cbl A and cbl B patients; in response to cobalamin supplements, marked decreases in the concentration of methylmalonic acid in blood or urine were reported in most cbl A patients and in nearly half the cbl B patients, but not in mut degrees or mut- patients; and finally, most cbl A, cbl B, and mut- patients were still living, whereas most mut degrees patients died during the first few months of life. Our data indicate that genotypic classification of the methylmalonic acidemias has prognostic and therapeutic use as well as diagnostic value.
This article has been cited by other articles:
Wikoff, W. R., Gangoiti, J. A., Barshop, B. A., Siuzdak, G.
(2007). Metabolomics Identifies Perturbations in Human Disorders of Propionate Metabolism. Clin. Chem.
53: 2169-2176
[Abstract][Full Text]
Korotkova, N., Lidstrom, M. E.
(2004). MeaB Is a Component of the Methylmalonyl-CoA Mutase Complex Required for Protection of the Enzyme from Inactivation. J. Biol. Chem.
279: 13652-13658
[Abstract][Full Text]
Peters, H., Nefedov, M., Sarsero, J., Pitt, J., Fowler, K. J., Gazeas, S., Kahler, S. G., Ioannou, P. A.
(2003). A Knock-out Mouse Model for Methylmalonic Aciduria Resulting in Neonatal Lethality. J. Biol. Chem.
278: 52909-52913
[Abstract][Full Text]
Klose, D. A., Kolker, S., Heinrich, B., Prietsch, V., Mayatepek, E., von Kries, R., Hoffmann, G. F.
(2002). Incidence and Short-Term Outcome of Children With Symptomatic Presentation of Organic Acid and Fatty Acid Oxidation Disorders in Germany. Pediatrics
110: 1204-1211
[Abstract][Full Text]
Dobson, C. M., Wai, T., Leclerc, D., Wilson, A., Wu, X., Dore, C., Hudson, T., Rosenblatt, D. S., Gravel, R. A.
(2002). Identification of the gene responsible for the cblA complementation group of vitamin B12-responsive methylmalonic acidemia based on analysis of prokaryotic gene arrangements. Proc. Natl. Acad. Sci. USA
99: 15554-15559
[Abstract][Full Text]
Okun, J. G., Horster, F., Farkas, L. M., Feyh, P., Hinz, A., Sauer, S., Hoffmann, G. F., Unsicker, K., Mayatepek, E., Kolker, S.
(2002). Neurodegeneration in Methylmalonic Aciduria Involves Inhibition of Complex II and the Tricarboxylic Acid Cycle, and Synergistically Acting Excitotoxicity. J. Biol. Chem.
277: 14674-14680
[Abstract][Full Text]
Watkins, D., Matiaszuk, N., Rosenblatt, D. S
(2000). Complementation studies in the cblA class of inborn error of cobalamin metabolism: evidence for interallelic complementation and for a new complementation class (cblH). J. Med. Genet.
37: 510-513
[Abstract][Full Text]
Burton, B. K.
(1998). Inborn Errors of Metabolism in Infancy: A Guide to Diagnosis. Pediatrics
102
: e69-e69
[Abstract][Full Text]
Nicolaides, P, Leonard, J, Surtees, R
(1998). Neurological outcome of methylmalonic acidaemia. Arch. Dis. Child.
78: 508-512
[Abstract][Full Text]
Narasimhan, P., Sklar, R., Murrell, M., Swanson, R. A., Sharp, F. R.
(1996). Methylmalonyl-CoA Mutase Induction by Cerebral Ischemia and Neurotoxicity of the Mitochondrial Toxin Methylmalonic Acid. J. Neurosci.
16: 7336-7346
[Abstract][Full Text]
Padmakumar, R., Banerjee, R.
(1995). Evidence from Electron Paramagnetic Resonance Spectroscopy of the Participation of Radical Intermediates in the Reaction Catalyzed by Methylmalonyl-coenzyme A Mutase. J. Biol. Chem.
270: 9295-9300
[Abstract][Full Text]
